Literature DB >> 17586744

Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes.

Klaus Rave1, Tim Heise, Andreas Pfützner, Anders H Boss.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17586744     DOI: 10.2337/dc07-0478

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  11 in total

1.  Pharmacokinetics and postprandial glycemic excursions following insulin lispro delivered by intradermal microneedle or subcutaneous infusion.

Authors:  Elaine McVey; Laurence Hirsch; Diane E Sutter; Christoph Kapitza; Sibylle Dellweg; Janina Clair; Kerstin Rebrin; Kevin Judge; Ronald J Pettis
Journal:  J Diabetes Sci Technol       Date:  2012-07-01

Review 2.  Inhaled aerosolized insulin: a "topical" anti-inflammatory treatment for acute lung injury and respiratory distress syndrome?

Authors:  Haim Shapiro; Ilya Kagan; Michal Shalita-Chesner; Joelle Singer; Pierre Singer
Journal:  Inflammation       Date:  2010-10       Impact factor: 4.092

Review 3.  Inhaled insulin: overview of a novel route of insulin administration.

Authors:  Lucy D Mastrandrea
Journal:  Vasc Health Risk Manag       Date:  2010-03-03

4.  Psychometric properties of an instrument for assessing the experience of patients treated with inhaled insulin: the inhaled insulin treatment questionnaire (IITQ).

Authors:  Richard R Rubin; Mark Peyrot
Journal:  Health Qual Life Outcomes       Date:  2010-03-24       Impact factor: 3.186

5.  Inhaled Technosphere insulin in comparison to subcutaneous regular human insulin: time action profile and variability in subjects with type 2 diabetes.

Authors:  Klaus Rave; Tim Heise; Lutz Heinemann; Anders H Boss
Journal:  J Diabetes Sci Technol       Date:  2008-03

6.  Randomized forced titration to different doses of technosphere insulin demonstrates reduction in postprandial glucose excursions and hemoglobin A1c in patients with type 2 diabetes.

Authors:  Cees J Tack; Vladimir Christov; Bastiaan E de Galan; Karl-Michael Derwahl; Gerhard Klausmann; Terezie Pelikánová; Jindra Perusicová; Anders H Boss; Nikhil Amin; David Kramer; Richard Petrucci; Wen Yu
Journal:  J Diabetes Sci Technol       Date:  2008-01

7.  Inhaled insulin is associated with prolonged enhancement of glucose disposal in muscle and liver in the canine.

Authors:  Dale S Edgerton; Alan D Cherrington; Doss W Neal; Melanie Scott; Margaret Lautz; Nancy Brown; Jeff Petro; Charles H Hobbs; Chet Leach; Angelo Del Parigi; Thomas R Strack
Journal:  J Pharmacol Exp Ther       Date:  2008-12-19       Impact factor: 4.030

Review 8.  Ultrafast-acting insulins: state of the art.

Authors:  Lutz Heinemann; Douglas B Muchmore
Journal:  J Diabetes Sci Technol       Date:  2012-07-01

Review 9.  Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled Insulin.

Authors:  Lutz Heinemann; Robert Baughman; Anders Boss; Marcus Hompesch
Journal:  J Diabetes Sci Technol       Date:  2016-07-09

10.  Efficacy and safety of Technosphere inhaled insulin compared with Technosphere powder placebo in insulin-naive type 2 diabetes suboptimally controlled with oral agents.

Authors:  Julio Rosenstock; Richard Bergenstal; Ralph A Defronzo; Irl B Hirsch; David Klonoff; Anders H Boss; David Kramer; Richard Petrucci; Wen Yu; Brian Levy
Journal:  Diabetes Care       Date:  2008-08-04       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.